NCT06563999 2026-04-21
NUMER
Sun Yat-sen University
Phase 2 Recruiting
Clinical Trials
3 trialsNCT03737994 2026-04-07
Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT03608007 2020-01-09
X-396 Capsule in Advanced NSCLC Patients With ROS1 Gene Rearrangement
Betta Pharmaceuticals Co., Ltd.
Phase 2 Unknown